Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Quanta Pharma Retatrutide 50mg Specifications Retatrutide 50mg by Quanta Pharma Quanta Pharma Retatrutide Research Benefits Triple receptor action - Targets GLP-1, GIP, and Glucagon receptors for the most comprehensive metabolic research available Superior weight management - Clinical trials showed greater weight reduction compared to dual agonists like Tirzepatide Enhanced fat oxidation - Glucagon receptor activation promotes direct fat burning and energy expenditure Glycemic control - Researched for improving insulin sensitivity and glucose metabolism Extended half-life - Approximately 6 days allows for once-weekly administration in research protocols How Quanta Pharma Retatrutide Works Quanta Pharma Retatrutide is a triple agonist peptide that simultaneously activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor
Your first payment processes immediately and your order ships normally
Apply topical GHK-Cu 1% on non-injection days
For patients and clinicians interested in accessing retatrutide prior to potential approval, participation in registered clinical trials is the appropriate route
nc iki esansiyel amino asit olan lizin-metionin ve kofaktrler (C, B3, B6 ve Demir) yeterli miktarda bulunduunda vcut tarafndan sentezlenebilir (1)
US$ 24.96
US$ 29.17
US$ 22.93
US$ 21.43
